Cytomegalovirus-Specific CD4 and CD8 T Cell Responses in Infants and Children

Scandinavian Journal of Immunology

Volumn 77, Issue 2, 2013, Pages 135-143

  Lidehall A K ^a   Engman, M L ^b   Sund, F ^c   Malm, G ^b   Lewensohn Fuchs, I ^b   Ewald, U ^c   Totterman T H ^a   Karltorp, E ^a   Korsgren, O ^a   Eriksson, B M ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOMEGALOVIRUS ANTIGEN; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; INFANT; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADOLESCENT; ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EPITOPES, T-LYMPHOCYTE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTERFERON-GAMMA; LYMPHOCYTE COUNT; MALE; TWINS; YOUNG ADULT;

EID: 84872874085     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/sji.12013     Document Type: Article

References (52)

1. Gaytant MA, Galama JM, Semmekrot BA et al. The incidence of congenital cytomegalovirus infections in The Netherlands. J Med Virol 2005;76:71-5.
2. Ahlfors K, Ivarsson SA, Harris S. Report on a long-term study of maternal and congenital cytomegalovirus infection in Sweden. Review of prospective studies available in the literature. Scand J Infect Dis 1999;31:443-57.
3. Griffiths PD, Baboonian C, Rutter D, Peckham C. Congenital and maternal cytomegalovirus infections in a London population. Br J Obstet Gynaecol 1991;98:135-40.
4. Murph JR, Souza IE, Dawson JD et al. Epidemiology of congenital cytomegalovirus infection: maternal risk factors and molecular analysis of cytomegalovirus strains. Am J Epidemiol 1998;147:940-7.
5. Stagno S. In: Remington J, Klein S, eds. Infectious Diseases of the Fetus & Newborn infant, 5th edn. Philadelphia, PA: W B Saunders, 2001:389-424.
6. Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 2007;17:355-63.
7. Cannon MJ, Davis KF. Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health 2005;5:70.
8. Boppana SB, Pass RF, Britt WJ, Stagno S, Alford CA. Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J 1992;11:93-9.
9. Jones CA. Congenital cytomegalovirus infection. Curr Probl Pediatr Adolesc Health Care 2003;33:70-93.
10. Coats DK, Demmler GJ, Paysse EA, Du LT, Libby C. Ophthalmologic findings in children with congenital cytomegalovirus infection. J AAPOS 2000;4:110-6.
11. Kylat RI, Kelly EN, Ford-Jones EL. Clinical findings and adverse outcome in neonates with symptomatic congenital cytomegalovirus (SCCMV) infection. Eur J Pediatr 2006;165:773-8.
12. Fowler KB, McCollister FP, Dahle AJ, Boppana S, Britt WJ, Pass RF. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr 1997;130:624-30.
13. Malm G, Engman ML. Congenital cytomegalovirus infections. Semin Fetal Neonatal Med 2007;12:154-9.
14. Michaels MG. Treatment of congenital cytomegalovirus: where are we now? Expert Rev Anti Infect Ther 2007;5:441-8.
15. Zanghellini F, Boppana SB, Emery VC, Griffiths PD, Pass RF. Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. J Infect Dis 1999;180:702-7.
16. Ling PD, Lednicky JA, Keitel WA et al. The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: a 14-month longitudinal study. J Infect Dis 2003;187:1571-80.
17. Tu W, Chen S, Sharp M et al. Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children. J Immunol 2004;172:3260-7.
18. Adler SP. Molecular epidemiology of cytomegalovirus: a study of factors affecting transmission among children at three day-care centers. Pediatr Infect Dis J 1991;10:584-90.
19. Saigal S, Lunyk O, Larke RP, Chernesky MA. The outcome in children with congenital cytomegalovirus infection. A longitudinal follow-up study. Am J Dis Child 1982;136:896-901.
20. Pass RF, Stagno S, Britt WJ, Alford CA. Specific cell-mediated immunity and the natural history of congenital infection with cytomegalovirus. J Infect Dis 1983;148:953-61.
21. Noyola DE, Demmler GJ, Williamson WD et al. Cytomegalovirus urinary excretion and long term outcome in children with congenital cytomegalovirus infection. Congenital CMV Longitudinal Study Group. Pediatr Infect Dis J 2000;19:505-10.
22. Lanari M, Lazzarotto T, Venturi V et al. Neonatal Cytomegalovirus Blood Load and Risk of Sequelae in Symptomatic and Asymptomatic Congenitally Infected Newborns. Pediatrics 2006;117:76-83.
23. Michaels MG, Greenberg DP, Sabo DL, Wald ER. Treatment of children with congenital cytomegalovirus infection with ganciclovir. Pediatr Infect Dis J 2003;22:504-9.
24. Kimberlin DW, Lin CY, Sanchez PJ et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 2003;143:16-25.
25. Demmler GJ. Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis 1991;13:315-29.
26. Walter S, Atkinson C, Sharland M et al. Congenital cytomegalovirus: association between dried blood spot viral load and hearing loss. Arch Dis Child Fetal Neonatal Ed 2008;93:F280-5.
27. Reddehase MJ, Weiland F, Munch K, Jonjic S, Luske A, Koszinowski UH. Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J Virol 1985;55:264-73.
28. Reuter JD, Wilson JH, Idoko KE, van den Pol AN. CD4+ T-cell reconstitution reduces cytomegalovirus in the immunocompromised brain. J Virol 2005;79:9527-39.
29. Riddell SR, Watanabe KS, Goodrich JM, Li CR, Agha ME, Greenberg PD. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 1992;257:238-41.
30. Sester M, Sester U, Gartner B et al. Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation. Transplantation 2001;71:1287-94.
31. Herrmann B, Larsson VC, Rubin CJ et al. Comparison of a duplex quantitative real-time PCR assay and the COBAS Amplicor CMV Monitor test for detection of cytomegalovirus. J Clin Microbiol 2004;42:1909-14.
32. Yun Z, Lewensohn-Fuchs I, Ljungman P, Ringholm L, Jonsson J, Albert J. A real-time TaqMan PCR for routine quantitation of cytomegalovirus DNA in crude leukocyte lysates from stem cell transplant patients. J Virol Methods 2003;110:73-9.
33. Fischler B, Rodensjo P, Nemeth A, Forsgren M, Lewensohn-Fuchs I. Cytomegalovirus DNA detection on Guthrie cards in patients with neonatal cholestasis. Arch Dis Child Fetal Neonatal Ed 1999;80:F130-4.
34. Engman ML, Malm G, Engstrom L et al. Congenital CMV infection: prevalence in newborns and the impact on hearing deficit. Scand J Infect Dis 2008;40:935-42.
35. Comans-Bitter WM, de Groot R, van den Beemd R et al. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr 1997;130:388-93.
36. Lidehall AK, Sund F, Lundberg T, Eriksson BM, Totterman TH, Korsgren O. T cell control of primary and latent cytomegalovirus infections in healthy subjects. J Clin Immunol 2005;25:473-81.
37. Engstrand M, Lidehall AK, Totterman TH, Herrman B, Eriksson BM, Korsgren O. Cellular responses to cytomegalovirus in immunosuppressed patients: circulating CD8+ T cells recognizing CMVpp65 are present but display functional impairment. Clin Exp Immunol 2003;132:96-104.
38. Kern F, Faulhaber N, Frommel C et al. Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides. Eur J Immunol 2000;30:1676-82.
39. Nomura LE, Walker JM, Maecker HT. Optimization of whole blood antigen-specific cytokine assays for CD4(+) T cells. Cytometry 2000;40:60-8.
40. Chen SF, Tu WW, Sharp MA et al. Antiviral CD8 T cells in the control of primary human cytomegalovirus infection in early childhood. J Infect Dis 2004;189:1619-27.
41. Gibson L, Dooley S, Trzmielina S et al. Cytomegalovirus (CMV) IE1- and pp65-specific CD8+ T cell responses broaden over time after primary CMV infection in infants. J Infect Dis 2007;195:1789-98.
42. Gibson L, Piccinini G, Lilleri D et al. Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection. J Immunol 2004;172:2256-64.
43. van Leeuwen EM, Remmerswaal EB, Heemskerk MH, ten Berge IJ, van Lier RA. Strong selection of virus-specific cytotoxic CD4+ T-cell clones during primary human cytomegalovirus infection. Blood 2006;108:3121-7.
44. Gamadia LE, Remmerswaal EB, Weel JF et al. Primary immune responses to human CMV: a critical role for IFN-γ-producing CD4+ T cells in protection against CMV disease. Blood 2003;101:2686-92.
45. Mold JE, Michaelsson J, Burt TD et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 2008;322:1562-5.
46. Odeberg J, Plachter B, Branden L, Soderberg-Naucler C. Human cytomegalovirus protein pp65 mediates accumulation of HLA-DR in lysosomes and destruction of the HLA-DR alpha-chain. Blood 2003;101:4870-7.
47. Moutaftsi M, Mehl AM, Borysiewicz LK, Tabi Z. Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. Blood 2002;99:2913-21.
48. Lee AW, Hertel L, Louie RK et al. Human cytomegalovirus alters localization of MHC class II and dendrite morphology in mature Langerhans cells. J Immunol 2006;177:3960-71.
49. Gredmark S, Soderberg-Naucler C. Human cytomegalovirus inhibits differentiation of monocytes into dendritic cells with the consequence of depressed immunological functions. J Virol 2003;77:10943-56.
50. Gans H, DeHovitz R, Forghani B, Beeler J, Maldonado Y, Arvin AM. Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life. Vaccine 2003;21:3398-405.
51. Elbou Ould MA, Luton D, Yadini M et al. Cellular immune response of fetuses to cytomegalovirus. Pediatr Res 2004;55:280-6.
52. Kern F, Surel IP, Faulhaber N et al. Target structures of the CD8(+)-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited. J Virol 1999;73:8179-84.